81 related articles for article (PubMed ID: 12468514)
1. Sigma receptor scintigraphy with N-[2-(1'-piperidinyl)ethyl]-3-(123)I-iodo-4-methoxybenzamide of patients with suspected primary breast cancer: first clinical results.
Caveliers V; Everaert H; John CS; Lahoutte T; Bossuyt A
J Nucl Med; 2002 Dec; 43(12):1647-9. PubMed ID: 12468514
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, in vitro pharmacologic characterization, and preclinical evaluation of N-[2-(1'-piperidinyl)ethyl]-3-[125I]iodo-4-methoxybenzamide (P[125I]MBA) for imaging breast cancer.
John CS; Bowen WD; Fisher SJ; Lim BB; Geyer BC; Vilner BJ; Wahl RL
Nucl Med Biol; 1999 May; 26(4):377-82. PubMed ID: 10382840
[TBL] [Abstract][Full Text] [Related]
3. Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors.
John CS; Vilner BJ; Geyer BC; Moody T; Bowen WD
Cancer Res; 1999 Sep; 59(18):4578-83. PubMed ID: 10493511
[TBL] [Abstract][Full Text] [Related]
4. Sigma-receptor imaging by means of I123-IDAB scintigraphy: clinical application in melanoma and non-small cell lung cancer.
Everaert H; Flamen P; Franken PR; Verhaeghe W; Bossuyt A
Anticancer Res; 1997; 17(3B):1577-82. PubMed ID: 9179197
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological characterization of 4-[125I]-N-(N-benzylpiperidin-4-yl)-4-iodobenzamide: a high affinity sigma receptor ligand for potential imaging of breast cancer.
John CS; Vilner BJ; Gulden ME; Efange SM; Langason RB; Moody TW; Bowen WD
Cancer Res; 1995 Jul; 55(14):3022-7. PubMed ID: 7606722
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a novel iodinated sigma-2 receptor ligand as a cell proliferation marker.
Hou C; Tu Z; Mach R; Kung HF; Kung MP
Nucl Med Biol; 2006 Feb; 33(2):203-9. PubMed ID: 16546674
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of [125I]-N-(N-benzylpiperidin-4-yl)-4- iodobenzamide, a new sigma receptor radiopharmaceutical: high-affinity binding to MCF-7 breast tumor cells.
John CS; Vilner BJ; Bowen WD
J Med Chem; 1994 Jun; 37(12):1737-9. PubMed ID: 8021913
[No Abstract] [Full Text] [Related]
8. [Assessement of the usefulness of whole body scintigraphy after administration of 6 MBq of 131I in the diagnostic of breast cancer].
Gołkowski F; Sokołowski G; Gil J; Kostecka-Matyja M; Basta P; Sowa-Staszczak A; Szybiński Z; Hubalewska-Dydejczyk A
Przegl Lek; 2011; 68(2):92-5. PubMed ID: 21751517
[TBL] [Abstract][Full Text] [Related]
9. Differential accumulation of iodine-123-iodobenzamide in melanotic and amelanotic melanoma metastases in vivo.
Larisch R; Schulte KW; Vosberg H; Ruzicka T; Müller-Gärtner HW
J Nucl Med; 1998 Jun; 39(6):996-1001. PubMed ID: 9627332
[TBL] [Abstract][Full Text] [Related]
10. Substituted halogenated arylsulfonamides: a new class of sigma receptor binding tumor imaging agents.
John CS; Lim BB; Vilner BJ; Geyer BC; Bowen WD
J Med Chem; 1998 Jul; 41(14):2445-50. PubMed ID: 9651150
[TBL] [Abstract][Full Text] [Related]
11. Increased binding to sigma sites of N-[1'(2-piperidinyl)ethyl)-4-[I-125]-iodobenzamide (I-125-PAB) with onset of tumor cell proliferation.
Zamora PO; Moody TW; John CS
Life Sci; 1998; 63(18):1611-8. PubMed ID: 9806214
[TBL] [Abstract][Full Text] [Related]
12. 99mTc-labeled sigma-receptor-binding complex: synthesis, characterization, and specific binding to human ductal breast carcinoma (T47D) cells.
John CS; Lim BB; Geyer BC; Vilner BJ; Bowen WD
Bioconjug Chem; 1997; 8(3):304-9. PubMed ID: 9177835
[TBL] [Abstract][Full Text] [Related]
13. [Tumor scintigraphy using 123I-labeled estradiol in breast cancer--receptor scintigraphy].
Scheidhauer K; Müller S; Smolarz K; Bräutigam P; Briele B
Nuklearmedizin; 1991 Jun; 30(3):84-99. PubMed ID: 1871007
[TBL] [Abstract][Full Text] [Related]
14. Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer.
Papantoniou VJ; Souvatzoglou MA; Valotassiou VJ; Louvrou AN; Ambela C; Koutsikos J; Lazaris D; Christodoulidou JK; Sotiropoulou MG; Melissinou MJ; Perperoglou A; Tsiouris S; Zerva CJ
Breast Cancer Res; 2004; 6(2):R56-62. PubMed ID: 14979918
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, radiosynthesis, and in vitro evaluation of [131I]-5-iodo-N-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-2-yl)-ethyl]-2-methoxy-benzamide as a potential tumor imaging agent.
Xu YP; Yang M; Pan DH
Appl Radiat Isot; 2009 Apr; 67(4):594-7. PubMed ID: 19181532
[TBL] [Abstract][Full Text] [Related]
16. [123I]IBZM uptake in metastatic melanoma.
Maffioli LS; Mascheroni L; Clemente C; Baldini M; Castellani MR
J Nucl Biol Med (1991); 1993 Mar; 37(1):18-20. PubMed ID: 8329472
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor status in primary breast cancer: iodine 123-labeled cis-11beta-methoxy-17alpha-iodovinyl estradiol scintigraphy.
Bennink RJ; Rijks LJ; van Tienhoven G; Noorduyn LA; Janssen AG; Sloof GW
Radiology; 2001 Sep; 220(3):774-9. PubMed ID: 11526281
[TBL] [Abstract][Full Text] [Related]
18. Scintigraphic detection of melanoma metastases with a radiolabeled benzamide ([iodine-123]-(S)-IBZM).
Maffioli L; Mascheroni L; Mongioj V; Gasparini M; Baldini MT; Seregni E; Castellani MR; Cascinelli N; Buraggi GL
J Nucl Med; 1994 Nov; 35(11):1741-7. PubMed ID: 7965150
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m-methylene diphosphonate scintimammography to image primary breast cancer.
Piccolo S; Lastoria S; Mainolfi C; Muto P; Bazzicalupo L; Salvatore M
J Nucl Med; 1995 May; 36(5):718-24. PubMed ID: 7738640
[TBL] [Abstract][Full Text] [Related]
20. Visualizing ocular melanoma using iodine-123-N-(2-diethylaminoethyl)4-iodobenzamide SPECT.
Everaert H; Bossuyt A; Flamen P; Mertens J; Franken PR
J Nucl Med; 1997 Jun; 38(6):870-3. PubMed ID: 9189131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]